Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity

Author:

Drinković Nikša1,Beus Maja2ORCID,Barbir Rinea2,Debeljak Željko34ORCID,Tariba Lovaković Blanka2ORCID,Kalčec Nikolina2,Ćurlin Marija5,Bekavac Ana6ORCID,Gorup Dunja7,Mamić Ivan8,Mandić Dario4,Micek Vedran2,Turčić Petra8ORCID,Günday-Türeli Nazende9ORCID,Türeli Emre9,Vinković Vrček Ivana210ORCID

Affiliation:

1. Polyclinic Drinković, Zagreb, Croatia

2. Institute for Medical Research and Occupational Health, Zagreb, Croatia

3. JJ Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia

4. University Hospital Osijek, Osijek, Croatia

5. Croatian Catholic University, Zagreb, Croatia

6. University of Zagreb, School of Medicine, Zagreb, Croatia

7. Department of Neuroradiology, Klinik für Neuroradiology, Universitätspital Zürich Universitätsspital Zürich, 8006 Zürich, Switzerland

8. University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

9. MyBiotech GmbH, Überherrn, Germany

10. University of Rijeka, Faculty of Medicine, Rijeka, Croatia

Abstract

Nanoformulations decrease systemic toxicity effects of antitumor agents.

Funder

Hrvatska Zaklada za Znanost

European Regional Development Fund

H2020 Excellent Science

European Social Fund Plus

Publisher

Royal Society of Chemistry (RSC)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3